

S464
25th European Congress of Psychiatry / European Psychiatry 41S (2017) S405–S464
diseases. Human mitochondria with its own genetic material meet
the needs required for the assembly of subunits of the oxidative
phosphorylation (OXPHOS) complexes. A number of translational
inhibitors are known that could potentially effect translation of
mitochondrial protein synthesis. Among these puromycin, homo-
harringtonine and cyclohexamide were selected for the present
study. The effect of these translational inhibitors on mitochon-
drial gene expression for the treatment of neuroblastoma are not
well established. Therefore, in this study, we have investigated
the effects of these translational inhibitors on the expression of
human mitochondrial gene expression in SH-SY5Y neuroblastoma
cells.
We observed a significant effect on the level of mitochondrial trans-
cripts upon exposure to these translation inhibitors in SH-SY5Y
cells, however, the effects on expression of mitochondrial proteins
were minimal. This suggests that translational inhibitors might not
directly affect the abundance of mitochondrial proteins. Transla-
tional inhibitors induce significant effect on mitochondrial gene
expression that can be lead to the new-targeted therapy for treating
neuroblastoma.
Disclosure of interest
The author has not supplied his declaration
of competing interest.
http://dx.doi.org/10.1016/j.eurpsy.2017.01.517